Australia, July 15 -- Trogenix Ltd., owns the trademark (2540822) for 'TROGENIX' till Jan. 31, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical, medical or veterinary preparations and substances; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of neoplastic diseases; pharmaceutical preparations and products for the treatment of carcinomas and leukaemias; pharmaceutical preparations and products for the treatment of central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer hepatocellular carcinoma and metastatic tumours; enhancers or super-enhancer...